Vimarsana
Biggest News Aggregation in the World

Page 3 - Lai Wei News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lai Wei. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lai Wei Today - Breaking & Trending Today

Intranasal flu vaccine with nanoparticles offers robust protection, researchers find - Vimarsana News

Intranasal flu vaccine with nanoparticles offers robust protection, researchers find

ATLANTA—An influenza vaccine administered through the nose and constructed with nanoparticles that enhance immune response offers strong protection

Intranasal flu vaccine with nanoparticles offers robust protection - Vimarsana News

Intranasal flu vaccine with nanoparticles offers robust protection

An influenza vaccine administered through the nose and constructed with nanoparticles that enhance immune response offers strong protection against

Ascletis Announces Inclusion in New Catalogue of China National Reimbursement Drug List (NRDL) of ASCLEVIR®/ GANOVO® Regimen, an All-oral Direct Anti-HCV Therapy - Vimarsana News

Ascletis Announces Inclusion in New Catalogue of China National Reimbursement Drug List (NRDL) of ASCLEVIR®/ GANOVO® Regimen, an All-oral Direct Anti-HCV Therapy

HANGZHOU, China and SHAOXING, China, Dec. 2, 2021/ PRNewswire/-- Ascletis Pharma Inc. today announces that its all-oral direct anti-hepatitis C virus ASCLEVIR ®/ GANOVO ® regimen has been included in the Medicine Catalog for National Basic Medical Insurance, Work-Related Injury Insurance and Maternity Insurance. Ascletis was the leader for the Anti-HCV...

Ascletis Announces Inclusion in New Catalogue of China National Reimbursement Drug List (NRDL) of ASCLEVIR®/ GANOVO® Regimen, an All-oral Direct Anti-HCV Therapy - Vimarsana News

Ascletis Announces Inclusion in New Catalogue of China National Reimbursement Drug List (NRDL) of ASCLEVIR®/ GANOVO® Regimen, an All-oral Direct Anti-HCV Therapy

/PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces that its all-oral direct anti-hepatitis C virus (HCV) ASCLEVIR® (Ravidasvir)/ GANOVO®...

AI-Based Approach Crunches Real-World Data To Emulate Clinical Trials - Vimarsana News

AI-Based Approach Crunches Real-World Data To Emulate Clinical Trials

February 4, 2021 By Deborah Borfitz February 4, 2021 | A computer scientist at The Ohio State University (OSU) recently demonstrated the potential of artificial intelligence to crunch real-world data and emulate randomized clinical trials, speeding the pace of drug repurposing. The initial use case was focused on preventing heart failure and stroke in patients with coronary artery disease, but the model could be applied to any disease with a definable outcome, says Ping Zhang, who leads the Artificial Intelligence in Medicine Lab at OSU.  Zhang is senior author of a recently pub...